End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.89 CNY | -1.89% | 0.00% | +45.47% |
05-13 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
04-25 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+45.47% | 1.94B | |
+42.07% | 6.23B | |
-21.20% | 4.19B | |
+5.38% | 3.32B | |
-16.98% | 2.91B | |
-5.82% | 2.42B | |
-12.67% | 1.59B | |
-3.91% | 1.58B | |
+44.56% | 1.49B | |
-15.57% | 1.48B |
- Stock Market
- Equities
- 600285 Stock
- News Henan Lingrui Pharmaceutical Co., Ltd.
- Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug